The Global Resource For Connecting Buyers and Sellers

Sanifit Announces Results of the Phase II Clinical Trial of SNF472 in Patients with Calciphylaxis

PALMA, Spain and SAN DIEGO, March 6, 2018 /PRNewswire/ —
Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, announced today the completion of its Phase II clinical trial of SNF472, its lead candidate for the…